4-[3-[(cyclopropylsulfonylamino)methyl]piperidin-1-yl]-6-fluoroquinazoline-7-carboxamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]piperidine-1-sulfonamide;4-methyl-N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]benzenesulfonamide;N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide

C94H119F3N22O11S5 — CID 158707010

IUPAC4-[3-[(cyclopropylsulfonylamino)methyl]piperidin-1-yl]-6-fluoroquinazoline-7-carboxamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]piperidine-1-sulfonamide;4-methyl-N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]benzenesulfonamide;N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide
SMILESCc1ccc(S(=O)(=O)NCC2CCCN(c3ncnc4ccc(C)cc34)C2)cc1.Cc1ccc2ncnc(N3CCCC(CNS(=O)(=O)C4CC4)C3)c2c1.NC(=O)c1cc2ncnc(N3CCCC(CNS(=O)(=O)C4CC4)C3)c2cc1F.O=S(=O)(NCC1CCCN(c2ncnc3ccc(F)cc23)C1)C1CC1.O=S(=O)(NCC1CCCN(c2ncnc3ccc(F)cc23)C1)N1CCCCC1
InChIInChI=1S/C22H26N4O2S.C19H26FN5O2S.C18H22FN5O3S.C18H24N4O2S.C17H21FN4O2S/c1-16-5-8-19(9-6-16)29(27,28)25-13-18-4-3-11-26(14-18)22-20-12-17(2)7-10-21(20)23-15-24-22;20-16-6-7-18-17(11-16)19(22-14-21-18)24-8-4-5-15(13-24)12-23-28(26,27)25-9-2-1-3-10-25;19-15-6-14-16(7-13(15)17(20)25)21-10-22-18(14)24-5-1-2-11(9-24)8-23-28(26,27)12-3-4-12;1-13-4-7-17-16(9-13)18(20-12-19-17)22-8-2-3-14(11-22)10-21-25(23,24)15-5-6-15;18-13-3-6-16-15(8-13)17(20-11-19-16)22-7-1-2-12(10-22)9-21-25(23,24)14-4-5-14/h5-10,12,15,18,25H,3-4,11,13-14H2,1-2H3;6-7,11,14-15,23H,1-5,8-10,12-13H2;6-7,10-12,23H,1-5,8-9H2,(H2,20,25);4,7,9,12,14-15,21H,2-3,5-6,8,10-11H2,1H3;3,6,8,11-12,14,21H,1-2,4-5,7,9-10H2
InChIKeyIIFUGRNZKDTESU-UHFFFAOYSA-N
MW1950.46 g/mol
LogP11.22
Rot. Bonds26

About 4-[3-[(cyclopropylsulfonylamino)methyl]piperidin-1-yl]-6-fluoroquinazoline-7-carboxamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]piperidine-1-sulfonamide;4-methyl-N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]benzenesulfonamide;N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide

4-[3-[(cyclopropylsulfonylamino)methyl]piperidin-1-yl]-6-fluoroquinazoline-7-carboxamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]piperidine-1-sulfonamide;4-methyl-N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]benzenesulfonamide;N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide (PubChem CID 158707010) has the molecular formula C94H119F3N22O11S5 and a molecular weight of 1950.46 g/mol. Its IUPAC name is 4-[3-[(cyclopropylsulfonylamino)methyl]piperidin-1-yl]-6-fluoroquinazoline-7-carboxamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]piperidine-1-sulfonamide;4-methyl-N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]benzenesulfonamide;N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide.

Molecular Properties

Compound Name4-[3-[(cyclopropylsulfonylamino)methyl]piperidin-1-yl]-6-fluoroquinazoline-7-carboxamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]piperidine-1-sulfonamide;4-methyl-N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]benzenesulfonamide;N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide
PubChem CID158707010
Molecular FormulaC94H119F3N22O11S5
Molecular Weight1950.46 g/mol
Exact Mass1948.80
IUPAC Name4-[3-[(cyclopropylsulfonylamino)methyl]piperidin-1-yl]-6-fluoroquinazoline-7-carboxamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]piperidine-1-sulfonamide;4-methyl-N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]benzenesulfonamide;N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide
SMILESCc1ccc(S(=O)(=O)NCC2CCCN(c3ncnc4ccc(C)cc34)C2)cc1.Cc1ccc2ncnc(N3CCCC(CNS(=O)(=O)C4CC4)C3)c2c1.NC(=O)c1cc2ncnc(N3CCCC(CNS(=O)(=O)C4CC4)C3)c2cc1F.O=S(=O)(NCC1CCCN(c2ncnc3ccc(F)cc23)C1)C1CC1.O=S(=O)(NCC1CCCN(c2ncnc3ccc(F)cc23)C1)N1CCCCC1
InChIInChI=1S/C22H26N4O2S.C19H26FN5O2S.C18H22FN5O3S.C18H24N4O2S.C17H21FN4O2S/c1-16-5-8-19(9-6-16)29(27,28)25-13-18-4-3-11-26(14-18)22-20-12-17(2)7-10-21(20)23-15-24-22;20-16-6-7-18-17(11-16)19(22-14-21-18)24-8-4-5-15(13-24)12-23-28(26,27)25-9-2-1-3-10-25;19-15-6-14-16(7-13(15)17(20)25)21-10-22-18(14)24-5-1-2-11(9-24)8-23-28(26,27)12-3-4-12;1-13-4-7-17-16(9-13)18(20-12-19-17)22-8-2-3-14(11-22)10-21-25(23,24)15-5-6-15;18-13-3-6-16-15(8-13)17(20-11-19-16)22-7-1-2-12(10-22)9-21-25(23,24)14-4-5-14/h5-10,12,15,18,25H,3-4,11,13-14H2,1-2H3;6-7,11,14-15,23H,1-5,8-10,12-13H2;6-7,10-12,23H,1-5,8-9H2,(H2,20,25);4,7,9,12,14-15,21H,2-3,5-6,8,10-11H2,1H3;3,6,8,11-12,14,21H,1-2,4-5,7,9-10H2
InChIKeyIIFUGRNZKDTESU-UHFFFAOYSA-N
XLogP11.22
TPSA422.28 Ų
H-Bond Donors6
H-Bond Acceptors26
Rotatable Bonds26
Heavy Atoms135
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001950.46
LogP ≤ 511.22
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1026

Analyze 4-[3-[(cyclopropylsulfonylamino)methyl]piperidin-1-yl]-6-fluoroquinazoline-7-carboxamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]piperidine-1-sulfonamide;4-methyl-N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]benzenesulfonamide;N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[3-[(cyclopropylsulfonylamino)methyl]piperidin-1-yl]-6-fluoroquinazoline-7-carboxamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]piperidine-1-sulfonamide;4-methyl-N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]benzenesulfonamide;N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide?
The IUPAC name of 4-[3-[(cyclopropylsulfonylamino)methyl]piperidin-1-yl]-6-fluoroquinazoline-7-carboxamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]piperidine-1-sulfonamide;4-methyl-N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]benzenesulfonamide;N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide (CID 158707010) is 4-[3-[(cyclopropylsulfonylamino)methyl]piperidin-1-yl]-6-fluoroquinazoline-7-carboxamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]piperidine-1-sulfonamide;4-methyl-N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]benzenesulfonamide;N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide.
What is the SMILES notation for 4-[3-[(cyclopropylsulfonylamino)methyl]piperidin-1-yl]-6-fluoroquinazoline-7-carboxamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]piperidine-1-sulfonamide;4-methyl-N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]benzenesulfonamide;N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide?
The canonical SMILES for 4-[3-[(cyclopropylsulfonylamino)methyl]piperidin-1-yl]-6-fluoroquinazoline-7-carboxamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]piperidine-1-sulfonamide;4-methyl-N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]benzenesulfonamide;N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide is Cc1ccc(S(=O)(=O)NCC2CCCN(c3ncnc4ccc(C)cc34)C2)cc1.Cc1ccc2ncnc(N3CCCC(CNS(=O)(=O)C4CC4)C3)c2c1.NC(=O)c1cc2ncnc(N3CCCC(CNS(=O)(=O)C4CC4)C3)c2cc1F.O=S(=O)(NCC1CCCN(c2ncnc3ccc(F)cc23)C1)C1CC1.O=S(=O)(NCC1CCCN(c2ncnc3ccc(F)cc23)C1)N1CCCCC1.
What is the InChIKey of 4-[3-[(cyclopropylsulfonylamino)methyl]piperidin-1-yl]-6-fluoroquinazoline-7-carboxamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]piperidine-1-sulfonamide;4-methyl-N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]benzenesulfonamide;N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide?
The InChIKey is IIFUGRNZKDTESU-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H26N4O2S.C19H26FN5O2S.C18H22FN5O3S.C18H24N4O2S.C17H21FN4O2S/c1-16-5-8-19(9-6-16)29(27,28)25-13-18-4-3-11-26(14-18)22-20-12-17(2)7-10-21(20)23-15-24-22;20-16-6-7-18-17(11-16)19(22-14-21-18)24-8-4-5-15(13-24)12-23-28(26,27)25-9-2-1-3-10-25;19-15-6-14-16(7-13(15)17(20)25)21-10-22-18(14)24-5-1-2-11(9-24)8-23-28(26,27)12-3-4-12;1-13-4-7-17-16(9-13)18(20-12-19-17)22-8-2-3-14(11-22)10-21-25(23,24)15-5-6-15;18-13-3-6-16-15(8-13)17(20-11-19-16)22-7-1-2-12(10-22)9-21-25(23,24)14-4-5-14/h5-10,12,15,18,25H,3-4,11,13-14H2,1-2H3;6-7,11,14-15,23H,1-5,8-10,12-13H2;6-7,10-12,23H,1-5,8-9H2,(H2,20,25);4,7,9,12,14-15,21H,2-3,5-6,8,10-11H2,1H3;3,6,8,11-12,14,21H,1-2,4-5,7,9-10H2.
What are the key properties of 4-[3-[(cyclopropylsulfonylamino)methyl]piperidin-1-yl]-6-fluoroquinazoline-7-carboxamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]piperidine-1-sulfonamide;4-methyl-N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]benzenesulfonamide;N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide?
4-[3-[(cyclopropylsulfonylamino)methyl]piperidin-1-yl]-6-fluoroquinazoline-7-carboxamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]piperidine-1-sulfonamide;4-methyl-N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]benzenesulfonamide;N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide has a molecular weight of 1950.46 g/mol, XLogP of 11.22, 26 rotatable bonds, 6 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[3-[(cyclopropylsulfonylamino)methyl]piperidin-1-yl]-6-fluoroquinazoline-7-carboxamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide;N-[[1-(6-fluoroquinazolin-4-yl)piperidin-3-yl]methyl]piperidine-1-sulfonamide;4-methyl-N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]benzenesulfonamide;N-[[1-(6-methylquinazolin-4-yl)piperidin-3-yl]methyl]cyclopropanesulfonamide is sourced from PubChem (CID 158707010), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).